D.A. Davidson & Co. Bellus Health Inc. Transaction History

D.A. Davidson & Co.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$2.7 - $6.64 $337,959 - $831,128	-125,170 Closed	0 $0
Q2 2021 Aug 10, 2021	SELL	$3.11 - $4.61 $142,220 - $210,815	-45,730 Reduced 26.76%	125,170 $389,000
Q1 2021 May 07, 2021	BUY	$3.03 - $4.58 $402,384 - $608,224	132,800 Added 348.56%	170,900 $656,000
Q4 2020 Feb 10, 2021	BUY	$2.27 - $3.3 $86,487 - $125,730	38,100 New	38,100 $117,000

128K

Ticker BLU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,793,000
Description
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. Th...

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

Stay updated on D.A. Davidson & Co. with notifications on news.